A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies

Niina Veitonmäki, Anna Kostyn, Sonia Kołt, Aleksandra Ziemblicka, Beata Romanowska, Sabina Oleksy, Ewelina Krzywińska, Kamilla Sołtys, Łukasz Świderski, Piotr Naporowski, Piotr Mamczur, Monika Świtoń, Marek Orłowski, Ying Zhang, Jianming Xu, Anna Andrzejczak, Aleksandra Bielawska-Pohl, Lidia Karabon · 2025

Read A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies by Niina Veitonmäki, Anna Kostyn, Sonia Kołt, Aleksandra Ziemblicka, Beata Romanowska, Sabina Oleksy, Ewelina Krzywińska, Kamilla Sołtys, Łukasz Świderski, Piotr Naporowski, Piotr Mamczur, Monika Świtoń, Marek Orłowski, Ying Zhang, Jianming Xu, Anna Andrzejczak, Aleksandra Bielawska-Pohl, Lidia Karabon (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12753870.txt.

Description

Niina Veitonmaki and co-authors present a 2025 study of a new antibody drug aimed at a cancer target called ROR1. That target sits on many cancer B cells but barely appears in normal adult tissue. That makes it a clean aim for therapy. Blood cancers such as chronic lymphocytic leukemia still relapse often under current care. Older patients also face harsh side effects from standard drugs. The new antibody is fully human and tuned to rally immune killer cells.

In lab tests, the drug drove strong killing of tumor cells. It acted against both solid tumors and blood cancers in those tests. The tuning the team used boosts a process where immune cells destroy marked targets. A safer profile is the hope behind choosing a target absent from healthy tissue. The paper reports preclinical work, not patient results. It sets up the case for trials in people.

Catalog record

CREATORNiina Veitonmäki, Anna Kostyn, Sonia Kołt, Aleksandra Ziemblicka, Beata Romanowska, Sabina Oleksy, Ewelina Krzywińska, Kamilla Sołtys, Łukasz Świderski, Piotr Naporowski, Piotr Mamczur, Monika Świtoń, Marek Orłowski, Ying Zhang, Jianming Xu, Anna Andrzejczak, Aleksandra Bielawska-Pohl, Lidia Karabon
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12753870

Browse the full library · About the Tower of Babel